Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
86.84
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
Today 4:07 EDT
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.
Via
The Motley Fool
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
August 16, 2024
Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve...
Via
Benzinga
Exposures
COVID-19
Demystifying Moderna: Insights From 11 Analyst Reviews
August 15, 2024
Via
Benzinga
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
August 13, 2024
COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...
Via
Benzinga
Exposures
COVID-19
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to...
Via
Benzinga
Exposures
COVID-19
Smart Money Is Betting Big In MRNA Options
August 13, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
August 12, 2024
Via
Benzinga
3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown
August 13, 2024
Investors should closely watch these three biotech stocks as their strong prospects are likely to help the rebound from market volatility.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 08, 2024
Via
Benzinga
Expanding the Cloud for AI
August 08, 2024
Amazon, Alphabet, Microsoft, and Meta are all spending a ton of money to build out cloud capabilities to fuel the next phase of AI growth. But the market isn't sold on that spend yet.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What the Options Market Tells Us About Moderna
August 07, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
August 05, 2024
Via
Benzinga
Moderna's Ongoing Decline
August 01, 2024
Another wipeout: this one, the lovely pharma opportunists at Moderna (MRNA), which has already lost 80% of its value. Just 20% to go!
Via
Talk Markets
3 Undervalued Stocks With Room to Rally Even Higher
August 05, 2024
The latest market sell-off could be a great time to give the slate of undervalued stocks another look before tech reverses course.
Via
InvestorPlace
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Moderna sustained a rare downgrade on Monday following its guidance cut for the year.
Via
Investor's Business Daily
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
August 05, 2024
Via
Benzinga
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
August 05, 2024
BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID-19 vaccines shifted. R&D expenses rose due to late-stage oncology...
Via
Benzinga
Exposures
COVID-19
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
August 04, 2024
12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atlassian, MicroStrategy, New Oriental, and Western Digital.
Via
Benzinga
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
August 04, 2024
This biotech company's promising pipeline could result in multibillion-dollar revenue.
Via
The Motley Fool
Where Will Novavax Be in 5 Years?
August 03, 2024
Its been a good year so far for the biotech, but how long can it keep the momentum going?
Via
The Motley Fool
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
August 02, 2024
Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down from $4B. Analysts adjust price targets, citing competitive pressures from...
Via
Benzinga
Exposures
COVID-19
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
August 02, 2024
Apple and Meta had strong results, while AI spending remains robust.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
August 02, 2024
Moderna's vaccine magic is slowly losing its charm, as evidenced by the warning the company issued on Thursday but Ark reposed its faith in the company.
Via
Benzinga
3 AI-Powered Healthcare Stocks Transforming Medicine
August 02, 2024
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
US Stocks Close Lower As Apple, Amazon Report Earnings: Greed Index Moves To 'Fear' Zone
August 02, 2024
The CNN Fear and Greed index fell to 39.6, signaling Fear in the market. Dow Jones dropped 495 points, Nasdaq down 2.3%, S&P 500 down 1.37%.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Moves Lower; Moderna Shares Plunge
August 01, 2024
Via
Benzinga
Exposures
Fossil Fuels
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
August 01, 2024
Shares of Moderna (MRNA) have broken an important support level. This means a new downtrend may be forming.
Via
Benzinga
Moderna (MRNA) Q2 2024 Earnings Call Transcript
August 01, 2024
MRNA earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks To Watch Today: MRNA, META, And AMAT
August 01, 2024
Meta Platforms surged on strong earnings and AI progress, while Moderna plummeted after slashing its sales outlook and Applied Materials saw its stock drop after being denied funding under the CHIPS...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.